Now is an exciting time to be working in the biotech service industry. When I first started Explora, many biotech companies still had a traditional structure, with teams of chemists, biologists, pharmacologists, and regulatory personnel all working together under one roof, with dedicated equipment and facilities. However, as pharmaceutical partners and investors started to demand better capital efficiency and shortened development timelines, companies began to realize the advantages of outsourcing many of their R&D needs to high-quality contract research organizations (CROs). This trend toward virtualization of R&D is expected to continue, and Explora is excited to be at its forefront.
As a scientist, it has been personally fulfilling to see so many of our clients’ projects succeed over the years. Explora has proudly played a role in helping companies reach important milestones: obtaining grant funding, raising early investment capital, starting clinical trials, going public, being acquired, and bringing products to the market.
As Explora celebrates its expansion into new markets, I want to take a moment to thank all of our employees, clients, and collaborators who have been instrumental in defining our culture and helping us grow. Here’s to the future!